Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 394

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 394
---
LS does not have any formal agreements at this time for such supply and production, and NLS may also elect to enter into agreements with additional or alternative parties in the future. 200 Commercialization, Sales and Marketing Given its stage of development, NLS does not currently have an established internal sales, marketing or distribution infrastructure. If its product candidates are approved for marketing, NLS intends to commercialize its product candidates either alone or in partnership with others, where appropriate, to maximize the value of its product candidates. NLS expects to build its commercial infrastructure using a focused and efficient approach, initially, establishing market access, sales and marketing capabilities in a targeted manner that is appropriate for the relevant product opportunity. NLS believes that this approach will allow it to effectively reach patients and physicians and to maximize the commercial potential of its product candidates. Organizational Structure NLS is a Swiss stock corporation organized under the laws of Switzerland. NLS’s Swiss enterprise identification number is CHE -447.067.367. NLS’s registered and principal executive offices are located at The Circle6, Postfach, 8058 Zurich, Switzerland. NLS’s general telephone number is (41) 44 512 21 50 and its internet address is www.nlspharma.com. In April 2021, NLS formed a wholly owned subsidiary, NLS Pharmaceutics Inc., a Delaware corporation. In November 2024 NLS also formed Merger Sub, its wholly owned subsidiary, in connection with the Merger. NLS did not have any other subsidiaries as of December 31, 2024, and as of the date of this proxy statement/prospectus. Property, Plant and Equipment NLS’s principal executive office in Postfach, 8058 Zurich, Switzerland, consists of approximately 25 square meters (approximately 270 square feet) of shared office space under an indefinite term lease that may be terminated by either party with one -monthprior notice. NLS believes that its current office space is sufficient to meet its anticipated needs for the foreseeable future and is suitable for the conduct of its business; provided, however, that NLS may require additional space and facilities as its business expands. Legal Proceedings From time to time NLS may become involved in legal proceedings that arise in the ordinary course of business. During the period covered by the financial statements contained herein, NLS was not subject to any material legal proceedings that has had a material adverse effect on its financial position, except as described below. No assurance can be given that future